BMO Capital maintains Outperform on Beam Therapeutics stock
BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...
Watch live: Powell testifies before Senate Banking Committee
Federal Reserve Chair Jerome Powell will sit before the Senate Banking Committee on Tuesday morning to testify on the agency’s monetary policy. The hearing comes as interest rates were held ...
news.stocktradersdaily6h
(BMO) Strategic Equity Report
February 11, 2025, 03:39 AM ET, BY Momei, Contributor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...
Bank of Montreal stock falls Monday, underperforms market
Bank of Montreal closed 3.6% below its 52-week high of C$147.54, which the company reached on December 6th.
BMO lifts O'Reilly stock price target to $1,450, keeps Outperform rating
BMO Capital Markets maintained a positive outlook on O'Reilly Automotive (NASDAQ:ORLY) shares, elevating the price target ...